Publication:
Nano-sized crystalline drug production by milling technology

dc.contributor.authorKunikazu Moribeen_US
dc.contributor.authorKeisuke Uedaen_US
dc.contributor.authorWaree Limwikranten_US
dc.contributor.authorKenjirou Higashien_US
dc.contributor.authorKeiji Yamamotoen_US
dc.contributor.otherChiba Universityen_US
dc.contributor.otherMahidol Universityen_US
dc.date.accessioned2018-10-19T05:42:38Z
dc.date.available2018-10-19T05:42:38Z
dc.date.issued2013-11-25en_US
dc.description.abstractNano-formulation of poorly water-soluble drugs has been developed to enhance drug dissolution. In this review, we introduce nano-milling technology described in recently published papers. Factors affecting the size of drug crystals are compared based on the preparation methods and drug and excipient types. A top-down approach using the comminution process is a method conventionally used to prepare crystalline drug nanoparticles. Wet milling using media is well studied and several wet-milled drug formulations are now on the market. Several trials on drug nanosuspension preparation using different apparatuses, materials, and conditions have been reported. Wet milling using a high-pressure homogenizer is another alternative to preparing production-scale drug nanosuspensions. Dry milling is a simple method of preparing a solid-state drug nano-formulation. The effect of size on the dissolution of a drug from nanoparticles is an area of fundamental research, but it is sometimes incorrectly evaluated. Here, we discuss evaluation procedures and the associated problems. Lastly, the importance of quality control, process optimization, and physicochemical characterization are briefly discussed. © 2013 Bentham Science Publishers.en_US
dc.identifier.citationCurrent Pharmaceutical Design. Vol.19, No.35 (2013), 6246-6258en_US
dc.identifier.doi10.2174/1381612811319350003en_US
dc.identifier.issn18734286en_US
dc.identifier.issn13816128en_US
dc.identifier.other2-s2.0-84887925688en_US
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/20.500.14594/32725
dc.rightsMahidol Universityen_US
dc.rights.holderSCOPUSen_US
dc.source.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84887925688&origin=inwarden_US
dc.subjectPharmacology, Toxicology and Pharmaceuticsen_US
dc.titleNano-sized crystalline drug production by milling technologyen_US
dc.typeReviewen_US
dspace.entity.typePublication
mu.datasource.scopushttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84887925688&origin=inwarden_US

Files

Collections